Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas

This study has been completed.

Study NCT00074646 Information provided by Celgene Corporation

First Received: December 17, 2003 Last Updated: January 2, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	June 2005
Estimated Primary Completion Date:	No date given